Anasens is a highly disruptive start-up (deep tech) developing an innovative quantitative and connected molecular detection platform for blood or saliva analysis, at home or at a point of service, in less than 5 minutes. This new technology from the lab of Prof Vallée-Bélisle, Chair of Research from Canada in Bioengineering and Bio-nanotechnology, has been developed at UdeM for more than 10 years and for more than 6 years in collaboration with international industry leaders.
| Website | http://www.anasens.com |
| Employees | 14 (8 on RocketReach) |
| Industry | Nanotechnology Research |
| Keywords | Molecular Diagnostics, Rapid Diagnostic Tests, Blood Analysis, Saliva Testing, Diagnostic Platform, Point Of Care Testing, Medical Diagnostics, In Vitro Diagnostics, Diagnostic Tools, Clinical Diagnostics, Home Diagnostics, At Home Testing, Early Disease Detection, Connected Health, Health Technology, Biotechnology, Medical Devices, Lab On A Chip |
| Competitors | Microsoft, IBM, Google, SAS, DataRobot, Alteryx, Tableau, TIBCO Streaming, H2O.ai, Altair RapidMiner +48 more (view full list) |
Looking for a particular Anasens employee's phone or email?
Véronique Bougie is the COO of Anasens.
8 people are employed at Anasens.
Anasens is based in Montréal, Québec.